title: Mycobacterium tuberculosis bacteraemia: experience from a non-endemic urban centre.
abstract: The isolation of Mycobacterium tuberculosis from blood culture specimens has been associated with human immunodeficiency virus (HIV) co-infection with variable impact on tuberculosis (TB) mortality reported. The overwhelming majority of M. tuberculosis bacteraemia cases were described in developing countries. We present a nested case-control analysis of clinical, sociodemographic and behavioural risk factors in patients with positive M. tuberculosis blood cultures compared with patients with negative blood cultures from a 9-year population-based active TB surveillance study conducted in Houston, Texas. There were 42 patients with M. tuberculosis bacteraemia, 47 blood culture negative patients and 3573 patients for whom no mycobacterial blood culture was requested. HIV infection was more common in patients for whom a mycobacterial blood culture was requested (79.8% versus 15.1% p <0.001). Of the patients with M. tuberculosis bacteraemia, six were HIV negative or had no documentation of HIV status, including five with immunosuppressive conditions other than HIV. Patients with M. tuberculosis bacteraemia were more likely than patients with negative blood cultures to be deceased at diagnosis or to die while on TB therapy (50.0% versus 17.0%, p <0.01), to report men-who-have-sex-with-men behaviour (31.7% versus 13.0%, p 0.03), to have renal failure (28.6% versus 6.4%, p 0.01), and to have HIV RNA levels higher than 500 000 copies/mL (61.9% versus 17.2%, p ≤0.01). Requests for mycobacterial culture of blood specimens were more common in HIV-infected individuals, and the presence of M. tuberculosis bacteraemia was associated with a significant increase in mortality.
authors: Departments of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, TX, USA.
authors: H M
authors: HM
authors: El Sahly
authors: L D
authors: LD
authors: Teeter
authors: J M
authors: JM
authors: Musser
authors: E A
authors: EA
authors: Graviss
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D016022:Case-Control Studies; D060085:Coinfection; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000821:virology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009026:Mortality; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification*; D011159:Population Surveillance; D011446:Prospective Studies; D012307:Risk Factors; D013781:Texas / Q000453:epidemiology; D016896:Treatment Outcome; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D014505:Urban Population; D055815:Young Adult
chemical_list: D000995:Antitubercular Agents
keywords: Human immunodeficiency virus; Mycobacterium tuberculosis bacteraemia; mortality; outcomes; tuberculosis
references: Int J Tuberc Lung Dis. 2001 Aug;5(8):763-8
references: 11495268
references: Arch Intern Med. 1993 Feb 22;153(4):496-500
references: 8435029
references: Lancet. 1999 Oct 2;354(9185):1159-63
references: 10513709
references: Int J Tuberc Lung Dis. 2002 Dec;6(12):1067-74
references: 12546114
references: Int J Tuberc Lung Dis. 2001 Jan;5(1):80-6
references: 11263521
references: Eur J Clin Microbiol Infect Dis. 2008 Jun;27(6):423-31
references: 18189149
references: Arch Intern Med. 1997 Nov 10;157(20):2359-63
references: 9361577
references: AIDS. 2011 Jul 31;25(12):1505-13
references: 21610489
references: Clin Infect Dis. 2012 Jul;55(2):242-50
references: 22511551
references: Clin Microbiol Infect. 2010 Jun;16(6):627-30
references: 19709128
references: Emerg Infect Dis. 2009 Jun;15(6):899-904
references: 19523288
references: J Infect Dis. 2006 Sep 1;194(5):633-41
references: 16897662
references: Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9869-74
references: 9275218
references: J Infect. 2007 Dec;55(6):502-9
references: 17920686
references: N Engl J Med. 2010 Feb 25;362(8):697-706
references: 20181971